Logo

Crossref


1. Rapid detection of insulin by immune-enrichment with silicon-nanoparticle-assisted MALDI-TOF MS

- Yichao Wang

- Xinwei Han

- Zhaoyun Li

- Jiaogui Xie

2. Anestesia y diabetes en el perioperatorio

- Angélica Yanine López Ramírez

- Norma Elizabeth Carrillo Molina

- Jaime Pablo Antonio Ortega García

3. Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential

- Zhongwen Qi

- Dan Wu

- Zhipeng Yan

- Qing Wang

- Yiming Li

- Junnan Zhao

- Fengqin Xu

4. SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD

- Moein Ala

5. Les inhibiteurs des SGLT2 : traitement anti diabétiques et/ou de la prévention cardiovasculaire et/ou protection rénale ? Place au débat

- M. Krempf

6. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction

- Milton Packer

7. A treatment-based algorithm for identification of diabetes type in the National Health and Nutrition Examination Survey

- Mitra Mosslemi

- Hannah L. Park

- Christine E. McLaren

- Nathan D. Wong

8. Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis

- Maximilian Gabler

- Nils Picker

- Silke Geier

- Johannes Foersch

- Jens Aberle

- Stephan Martin

- Matthias Riedl

- Thomas Wilke

9. Hypoglycemic Effect of Calendula arvensis Flowers is Mediated by Digestive Enzyme Inhibition

- Abdul-Malik Abudunia

- Ilias Marmouzi

- Mourad Kharbach

- Meryem El Jemli

- Karima Sayah

- Abdelhakim Bouyahya

- Ali Al-kaf

- Ali Alyahawi

- M’Hammed Ansar

- Abdelaziz Bouklouze

- My El Abbes Faouzi

- Azeddine Ibrahimi

10. The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: A systematic review and network meta-analysis

- Yousef Alhindi

- Amanda Avery

11. Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study

- Akihiro Kudo

- Noritaka Machii

- Toshio Ono

- Haruka Saito

- Yoshito Oshiro

- Ryu Takahashi

- Koichi Oshiro

- Yoshinobu Taneda

- Moritake Higa

- Ken Nakachi

- Shusuke Yagi

- Hiroaki Masuzaki

- Masataka Sata

- Michio Shimabukuro

12. Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia

- Ashenafi Kibret Sendekie

- Achamyeleh Birhanu Teshale

- Yonas Getaye Tefera

- Ferdinando Carlo Sasso

13. Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019

- Jiyun Park

- Gyuri Kim

- Bong-Sung Kim

- Kyung-Do Han

- So Yoon Kwon

- So Hee Park

- You-Bin Lee

- Sang-Man Jin

- Jae Hyeon Kim

14. Human Insulin Versus Insulin Analogues: A True Companion Forgotten

- Hengameh Abdi

15. Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study

- Nadia Gul

- Inayat Ur Rehman

- Yasar shah

- Arbab Muhammad Ali

- Zahid Ali

- Omer Shehzad

- Khang Wen Goh

- Long Chiau Ming

- Amal K. Suleiman

- Nimesh Lageju

16. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

- Ofri Mosenzon

- Thalia Marie Blicher

- Signe Rosenlund

- Jan W Eriksson

- Simon Heller

- Ole Holm Hels

- Richard Pratley

- Thozhukat Sathyapalan

- Cyrus Desouza

- R Abramof

- D Alpenidze

- S Aronoff

- K Astamirova

- B Barker

- G Bedel

- L Belousova

- M Benson

- I Beshay

- W Biggs

- K Blaze

- P Bogdanski

- R Busch

- S Chaidarun

- S Chandran

- A Chang

- S Chilka

- A Cleland

- L Connery

- G Cornett

- B Delgado

- C Desouza

- T Donner

- K Eliasson

- J Eriksson

- S Folkerth

- K Forshaw

- H A Frandsen

- E Frolova

- W Gandy

- G Gatipon

- A Golovach

- L Gonzalez-Orozco

- J Gumprecht

- E Haddad

- T K Hansen

- T Hart

- S Hasan

- B Hella

- S Heller

- M Hellgren

- M Hewitt

- S Hietaniemi

- M Hitz

- P Houser

- R Huntley

- R Jackson

- P E Jakobsen

- A Kapoor

- L Kargina

- E Kazakova

- K Khan

- E Klein

- H Knoble

- N Krasnopeeva (Kabachkova)

- A Krzeminski

- M Kunitsyna

- J Lawhead

- K Levin

- P Levin

- L Lewy-Alterbaum

- S Lindmark

- R Lindsay

- A Luts

- T Lysenko

- S Madsbad

- T Maxwell

- C Mbogua

- J Mcknight

- K Metsärinne

- T Milovanova

- E Morawski

- O Mosenzon

- D Nabriski

- H Nguyen

- P Nicol

- S Nieminen

- A Nikkola

- P Norwood

- P O'Donnell

- A Odugbesan

- J Parker

- Y Pergaeva

- A Peskov

- S Plevin

- J Pouzar

- R Pratley

- J Reed

- P Rossing

- T Sathyapalan

- M Sergeeva-Kondrachenko

- Z Shaikh

- M Shamkhalova

- N Shehadeh

- Y Shlesinger

- R Silver

- B Snyder

- J Soufer

- J Strand

- S Sulosaari

- A Tirosh

- H Traylor

- N Uhlenius

- G Vagapova

- M Yanovskaya

- L Zarutskaya

- E Zhdanova

17. Hibiscus sabdariffa in Diabetes Prevention and Treatment—Does It Work? An Evidence-Based Review

- Daniel Jamrozik

- Weronika Borymska

- Ilona Kaczmarczyk-Żebrowska

18. Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach

- Ashok Kumar Das

- Banshi Saboo

- Rajeev Chawla

- S. R. Aravind

- Rajesh Rajput

- Awadhesh K. Singh

- J. J. Mukherjee

- Ashok Jhingan

- Parag Shah

- Vaishali Deshmukh

- Shailaja Kale

- Shalini Jaggi

- G. R. Sridhar

- Rajnish Dhediya

- Kumar Gaurav

19.